Enamine Provides Exquiron With Large Novel Diverse Screening Compound Library Enamine Ltd, a leading provider of screening compounds, chemical building blocks and discovery services, and Exquiron Biotech AG, a company specializing in early stage drug discovery services, recently announced a multiyear collaboration under which Enamine will provide a carefully selected, novel diverse screening compound library
June 5, 2013 - DrugDiscoveryOnline